Aquestive Therp Rg

Aquestive Therapeutics, Inc. develops and commercializes oral and sublingual film formulations for CNS disorders and emergency care, including Suboxone for opioid dependence and Sympazan for Lennox‑Gastaut syndrome, with a pipeline of phase‑3 anaphylaxis and Parkinson’s agents.

Headquarters: United States (USA)

Aquestive Therp Rg Logo
Company Profile
  • Employees: 142
  • HQ: Warren
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
AQST Aquestive Therp Rg
Cap: 0.5B
EQUITY NGM USD US03843E1047 Active
📈
Home Login